These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3933210)

  • 1. On the possibility of cross-resistance between rifampicin and clofazimine in mycobacteria--a laboratory study.
    Urbanczik R
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Aug; 260(1):113-6. PubMed ID: 3933210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of opportunist mycobacteria to rifampicin and ethambutol.
    Yates MD; Collins CH
    Tubercle; 1981 Jun; 62(2):117-21. PubMed ID: 7303160
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Luo J; Yu X; Jiang G; Fu Y; Huo F; Ma Y; Wang F; Shang Y; Liang Q; Xue Y; Huang H
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on clofazimine-resistance in mycobacteria: is the inability to isolate drug-resistance mutants related to its mode of action?
    David HL; Rastogi N; Clavel-Sérès S; Clément F
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Aug; 266(1-2):292-304. PubMed ID: 3122464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
    De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
    J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth.
    Wallace RJ; Nash DR; Steele LC; Steingrube V
    J Clin Microbiol; 1986 Dec; 24(6):976-81. PubMed ID: 3097069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activity of ciprofloxacin against clinical isolates of mycobacteria resistant to antimycobacterial drugs.
    Marinis E; Legakis NJ
    J Antimicrob Chemother; 1985 Oct; 16(4):527-30. PubMed ID: 2933382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro investigation of the antimicrobial activities of novel tetramethylpiperidine-substituted phenazines against Mycobacterium tuberculosis.
    van Rensburg CE; Jooné GK; Sirgel FA; Matlola NM; O'Sullivan JF
    Chemotherapy; 2000; 46(1):43-8. PubMed ID: 10601797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifampicin-susceptibility and rifampicin-resistance in mycobacteria.
    Manten A; van Wijngaarden LJ; van Klingeren B
    Acta Tuberc Pneumol Belg; 1969; 60(3):329-34. PubMed ID: 4984415
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium fortuitum and Mycobacterium chelonei to augmentin.
    Casal M; Rodriguez F; Benavente M; Luna M
    Eur J Clin Microbiol; 1986 Aug; 5(4):453-4. PubMed ID: 3093225
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cross-resistance between rifampin and rifabutin in multidrug resistant Mycobacterium tuberculosis complex strains].
    Gao L; Xiao HP; Hu ZY; Cui ZL; Lu JM; Shen XN
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 May; 35(5):333-5. PubMed ID: 22883990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.
    Texier-Maugein J; Mormède M; Fourche J; Bébéar C
    Eur J Clin Microbiol; 1987 Oct; 6(5):584-6. PubMed ID: 3125050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance Assessment of the BluePoint MycoID Plus Kit for Identification of Mycobacterium tuberculosis, Including Rifampin- and Isoniazid-resistant Isolates, and Nontuberculous Mycobacteria.
    Chien JY; Chang TC; Chiu WY; Yu CJ; Hsueh PR
    PLoS One; 2015; 10(5):e0125016. PubMed ID: 25938668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two groups of Mycobacterium avium complex strains determined according to the susceptibility to rifampicin and ansamycin.
    Tsukamura M
    Microbiol Immunol; 1987; 31(7):615-23. PubMed ID: 3125413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Ro 23-6240 on sensitive and resistant intracellular mycobacteria.
    Easmon C; Verity L
    Eur J Clin Microbiol; 1987 Apr; 6(2):165-6. PubMed ID: 3109896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of mycobacteria, especially of Mycobacterium intracellulare, to 5-fluorouracil and pattern of development of resistance of Mycobacterium tuberculosis to the drug.
    Tsukamura M
    Microbiol Immunol; 1979; 23(5):427-9. PubMed ID: 116112
    [No Abstract]   [Full Text] [Related]  

  • 17. Dynamic aspects of the activity of clofazimine against Mycobacterium intracellulare.
    Gangadharam PR; Pratt PF; Damle PB; Davidson PT
    Tubercle; 1981 Sep; 62(3):201-6. PubMed ID: 7314252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro activities of clofazimine against different drug-resistant types of Mycobacterium tuberculosis].
    Gui XW; Xiao HP; Hu ZY; Cui ZL; Wang J; Lu JM
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Aug; 34(8):579-81. PubMed ID: 22168978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sensitivity "in vitro" of human tubercular mycobacteria and atypical mycobacteria to rifampicin].
    Mandler F; Garimoldi M
    G Ital Mal Torace; 1969; ():Suppl 2:7-13. PubMed ID: 4982435
    [No Abstract]   [Full Text] [Related]  

  • 20. Genotyping and drug susceptibility testing of mycobacterial isolates from population-based tuberculosis prevalence survey in Ghana.
    Addo KK; Addo SO; Mensah GI; Mosi L; Bonsu FA
    BMC Infect Dis; 2017 Dec; 17(1):743. PubMed ID: 29197331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.